Volume 36, Issue 5, Pages (May 2012)

Slides:



Advertisements
Similar presentations
Volume 33, Issue 3, Pages (September 2010)
Advertisements

Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Volume 26, Issue 3, Pages (March 2007)
Volume 47, Issue 3, Pages e5 (September 2017)
Volume 26, Issue 5, Pages (May 2007)
Volume 42, Issue 5, Pages (May 2015)
Volume 30, Issue 1, Pages (January 2009)
Volume 30, Issue 4, Pages (April 2009)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Volume 43, Issue 2, Pages (August 2015)
A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells  Aixin Yu, Linjian Zhu, Norman H. Altman,
Volume 38, Issue 3, Pages (March 2013)
Volume 28, Issue 5, Pages (May 2008)
Volume 40, Issue 4, Pages (April 2014)
Volume 42, Issue 2, Pages (February 2015)
Volume 33, Issue 3, Pages (September 2010)
The Cellular Mechanism of Aire Control of T Cell Tolerance
Volume 37, Issue 4, Pages (October 2012)
Volume 46, Issue 1, Pages (January 2017)
Volume 33, Issue 6, Pages (December 2010)
Volume 29, Issue 5, Pages (November 2008)
Liying Guo, Jane Hu-Li, William E. Paul  Immunity 
Volume 28, Issue 6, Pages (June 2008)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 31, Issue 5, Pages (November 2009)
Volume 44, Issue 4, Pages (April 2016)
Volume 36, Issue 2, Pages (February 2012)
Volume 34, Issue 4, Pages (April 2011)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 37, Issue 3, Pages (September 2012)
Volume 21, Issue 8, Pages (November 2017)
Volume 27, Issue 5, Pages (November 2007)
Volume 37, Issue 5, Pages (November 2012)
Volume 32, Issue 5, Pages (May 2010)
Volume 34, Issue 3, Pages (March 2011)
Volume 42, Issue 1, Pages (January 2015)
Volume 36, Issue 1, Pages (January 2012)
Volume 44, Issue 5, Pages (May 2016)
Volume 40, Issue 4, Pages (April 2014)
Volume 17, Issue 2, Pages (February 2009)
Volume 23, Issue 3, Pages (April 2018)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 43, Issue 5, Pages (November 2015)
Volume 24, Issue 1, Pages (January 2006)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 44, Issue 4, Pages (April 2016)
Volume 44, Issue 1, Pages (January 2016)
Volume 27, Issue 4, Pages e4 (April 2019)
Volume 46, Issue 4, Pages (April 2017)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 126, Issue 6, Pages (September 2006)
Volume 31, Issue 4, Pages (October 2009)
Volume 37, Issue 5, Pages (November 2012)
Volume 41, Issue 4, Pages (October 2014)
Volume 34, Issue 3, Pages (March 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 30, Issue 4, Pages (April 2009)
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Volume 43, Issue 4, Pages (October 2015)
Yunqi Wang, Maureen A. Su, Yisong Y. Wan  Immunity 
Volume 32, Issue 6, Pages (June 2010)
Volume 31, Issue 6, Pages (December 2009)
Volume 39, Issue 5, Pages (November 2013)
Volume 23, Issue 4, Pages (October 2005)
Volume 22, Issue 3, Pages (March 2005)
Volume 37, Issue 2, Pages (August 2012)
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 45, Issue 5, Pages (November 2016)
Volume 39, Issue 2, Pages (August 2013)
Presentation transcript:

Volume 36, Issue 5, Pages 731-741 (May 2012) An N-Terminal Mutation of the Foxp3 Transcription Factor Alleviates Arthritis but Exacerbates Diabetes  Jaime Darce, Dipayan Rudra, Li Li, Junko Nishio, Daniela Cipolletta, Alexander Y. Rudensky, Diane Mathis, Christophe Benoist  Immunity  Volume 36, Issue 5, Pages 731-741 (May 2012) DOI: 10.1016/j.immuni.2012.04.007 Copyright © 2012 Elsevier Inc. Terms and Conditions

Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Foxp3fgfp Mice Exhibit Contrasting Phenotypes in Different Autoimmune Models (A) Schematic representation of FoxP3, GFP-FoxP3, and FoxP3-I-GFP. Protein convertase cleavage sites (RXXR), proline-rich regions (Pxxp1 and Pxxp2), and leucine zipper (Leu-zip) and forkhead (FKH) domains are represented. (B) Arthritis clinical score and ankle measurements of 8-week-old K/BxN.Foxp3fgfp males, K/BxN.Foxp3fgfp/wt heterozygote females, and WT littermate control mice. (C) Anti-GPI IgG reactivity in sera of 8-week-old K/BxN.Foxp3fgfp males, K/BxN.Foxp3fgfp/wt females, and WT littermate control mice (mean ± SD, n = 6–8). (D) Arthritis clinical score, ankle thickness, and anti-GPI antibodies in 8-week-old male and female K/BxN.Foxp3igfp and WT controls (mean ± SD, n = 6–8). (E) Diabetes incidence curves of NOD.Foxp3fgfp males NOD.Foxp3fgfp/wt, females and littermate controls (10 mice/group). Two different cohorts of NOD.Foxp3fgfp/wt heterozygous females were followed, in two different animal facilities. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Foxp3fgfp Disease Phenotype Does Not Correlate with an Alteration in Treg Cell Frequency (A and B) Percentage of FoxP3-positive cells within CD4+ T cells. (A) Spleens and draining lymph nodes (popliteal) of 8-week-old WT and K/BxN.Foxp3fgfp males (each point is an individual mouse). (B) Spleen and pancreas of 9-week-old NOD.Foxp3fgfp males and controls. (C) Proportion of FoxP3+ Treg cells among LN and visceral adipose tissue of 40-week-old B6 males. (D) Representative dot plots showing the percent FoxP3+ Helios− Treg cells in colon lamina propria and spleen of 6-week-old B6.Foxp3fgfp and B6.Foxp3igfp males. (E) Splenocytes from K/BxN.Foxp3fgfp/wt heterozygote females were stained with CD3, CD4, and FoxP3 antibodies. Gates and values represent the fraction of GFP-positive and -negative cells among FoxP3+ population. A summary of data in adjacent plot shows a fraction of GFP+ cells among FoxP3+ cells in the thymus, spleen, and draining lymph nodes of K/BxN.Foxp3fgfp/wt females; the dashed line denotes the 50/50 ratio expected from random X-chromosome inactivation. (F) Linear regression analysis of serum anti-GPI levels versus the fraction of GFP+ FoxP3+ Treg cells in K/BxN.Foxp3fgfp/wt heterozygote females. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 Decrease in Th17 Cells in K.BxN.Foxp3fgfp Mice Is Independent of Inherent Th17 Cell Differentiation Defect (A) IL-17a-producing cells in spleen and small intestine lamina propria from 4- to 5-week old K/BxN and K/BxN.Foxp3fgfp male mice. Gates and values represent fraction of IL-17a-positive cells in CD4 population. Data are summarized in adjacent graph. Data are representative of three independent experiments. (B) In vitro Th17 and Treg cell differentiation of congenically marked naive cells from WT (CD45.1) and Foxp3fgfp (CD45.2) B6 mice. Data is representative of two independent experiments. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 Elevated FoxP3 Expression in Foxp3fgfp Treg Cells (A) Anti-FoxP3 staining profiles of CD3+CD4+ cells from different organs of K/BxN.Foxp3fgfp male or WT littermates (shaded area is profile from isotype control). Data are representative of three independent experiments. (B) FoxP3 mean fluorescence intensity (MFI) of splenic Treg cells on three different backgrounds. Each dot represents an individual mouse, and values are normalized to the mean FoxP3 MFI of WT mice in each experiment. (C) FoxP3 MFI for LN and visceral fat from 40-week-old B6.Foxp3fgfp mice. (D) Foxp3 mRNA levels in CD4+GFP+ splenic Treg cells from Foxp3fgfp or WT male mice on two different backgrounds. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 Enhanced Treg Cell Function Observed in Foxp3fgfp Treg Cells (A) In vitro suppressive ability of CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT littermates, titrated at different ratios in cocultures with CD4+ Tconv responder cells and APCs. Data represent mean proliferation ± SD of three independent experiments. (B) Th17 cell differentiation suppressed by GFP-FoxP3 (FGFP) and FoxP3-ires-GFP (IGFP) Treg cells. Ifng, Il17a, and Il4 mRNA expression levels were assessed by quantitative RT-PCR. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 6 Biased Gene Expression in Foxp3fgfp Treg Cells Gene expression profiles were generated by microarray of Treg and Tconv cells from B6.Foxp3fgfp males, with parallel profiling from B6.Foxp3igfp as a reference. (A) Comparison of expression values in Treg versus Tconv splenocytes from Foxp3fgfp and Foxp3igfp B6 males. The canonical Treg cell signature is highlighted in red (Treg cell-upregulated transcripts) and blue (Treg cell-downregulated transcripts). (B) Comparison of expression values in Foxp3fgfp and control Foxp3igfp Treg splenocytes, on B6 and NOD backgrounds. Genes concordantly overexpressed in Foxp3fgfp relative to Foxp3igfp in both backgrounds are highlighted in red. Transcription factor genes are represented in green. (C) Heatmap representation of transcripts over-represented in Foxp3fgfp on both backgrounds. (D) Flow cytometric confirmation of CTLA-4, CD103, and KLRG1 overexpression in CD4+FoxP3+ Treg cells from spleens of Foxp3fgfp heterozygote females, on the K/BxN and NOD backgrounds. The values shown are the percent CD103 or KLRG1-positive cells within the GFP-positive or -negative fraction of Treg cells (mean ± SD of eight mice). (E) Overrepresentation of the IRF4 Treg cell signature: The ratio of expression in Foxp3fgfp versus Foxp3igfp of IRF4-responsive transcripts is shown (log2 scale) for both B6 and NOD data sets. The p value is calculated with a χ2 test for departure from a null hypothesis of random distribution. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 7 GFP-FoxP3 Differentially Binds Transcriptional Cofactors (A) Association of FoxP3 with FoxP1 determined by coimmunoprecipitation. Anti-FoxP3 was used for immunoprecipitating FoxP3 from nuclear lysates of CD4+CD25− Tconv or CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice, and immunoblots were probed for FoxP1 (anti-FoxP3 as control). (B) Nuclear lysates of B6.Foxp3fgfp and B6.Foxp3igfp CD25+ Treg cells were immunoprecipitated with anti-FoxP3 or control IgG and probed with anti-HIF1-α (anti-FoxP3 and anti-β-actin as controls). (C) Anti-IRF4 was used for immunoprecipitating IRF4 from nuclear lysates CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice and immunoblotted for FoxP3. (D) Immunoblot analysis of IRF4 from nuclear lysates of CD4+CD25+ Treg cells from B6.Foxp3fgfp or WT mice; three independent experiments are shown. Immunity 2012 36, 731-741DOI: (10.1016/j.immuni.2012.04.007) Copyright © 2012 Elsevier Inc. Terms and Conditions